Armistice Capital, LLC 13D and 13G filings for Aptose Biosciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-02-14 4:57 pm Sale |
2024-12-31 | 13G | Aptose Biosciences Inc. APTO |
Armistice Capital, LLC | 34,176 4.990% |
-30,998![]() (-47.56%) |
Filing |
2024-11-14 3:22 pm Purchase |
2024-09-30 | 13G | Aptose Biosciences Inc. APTO |
Armistice Capital, LLC | 65,173 9.990% |
65,173![]() (New Position) |
Filing |